Metropolitan Life Insurance CO Codiak Bio Sciences, Inc. Transaction History

Metropolitan Life Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.0 - $16.78 $51,520 - $86,450	-5,152 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$15.58 - $22.88 $80,268 - $117,877	5,152 New	5,152 $84,000
Q3 2021 Mar 30, 2023	BUY	$15.58 - $22.88 $80,268 - $117,877	5,152 New	5,152 $84,000
Q3 2021 Nov 15, 2021	BUY	$15.58 - $22.88 $80,268 - $117,877	5,152 New	5,152 $84,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.